A phase II trial of preoperative mitomycin, cisplatin and 5-fluorouracil in adenocarcinoma of the oesophagus

This publication has 20 references indexed in Scilit:

• A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
  New England Journal of Medicine, 1996
• The Role of Neoadjuvant Therapy in Surgically Resectable Esophageal Cancer
  Archives of Surgery, 1996
• Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagus
  Cancer Chemotherapy and Pharmacology, 1996
• Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction
  European Journal Of Cancer, 1995
• A phase II study of mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagus
  Clinical Oncology, 1994
• Continuing climb in rates of esophageal adenocarcinoma: an update
  Published by American Medical Association (AMA) ,1993
• Esophageal cancer: Does preoperative chemotherapy make a difference?
  Journal of Surgical Oncology, 1992
• A phase II study of 5-fluorouracil, adriamycin and mitomycin-C in adenocarcinoma of the oesophagus
  Clinical Oncology, 1991
• Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus
  The Annals of Thoracic Surgery, 1988
• Taxol: Mechanisms of Action and Resistancea
  Annals of the New York Academy of Sciences, 1986